ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment (Q38743865)

6 September 2017

title

ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment (English)

1 reference

6 September 2017

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Javier Hernandez-Losa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

Vicente García-Patos Briones

13 June 2020

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Juan Angel Recio

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

M Pérez-Alea

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

K McGrail

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

S Sánchez-Redondo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

B Ferrer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

G Fournet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

E Muñoz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

S Tenbaum

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

G Martin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

R Costello

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

I Ceylan

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

5 June 2017

1 reference

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

5695-5708

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581514%20AND%20SRC:MED&resulttype=core&format=json

Cancer treatment and survivorship statistics, 2016.

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Altered methional homoeostasis is associated with decreased apoptosis in BAF3 bcl2 murine lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Novel competitive irreversible inhibitors of aldehyde dehydrogenase (ALDH1): restoration of chemosensitivity of L1210 cells overexpressing ALDH1 and induction of apoptosis in BAF(3) cells overexpressing bcl(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Aldehyde dehydrogenase inhibitors: alpha,beta-acetylenic N-substituted aminothiolesters are reversible growth inhibitors of normal epithelial but irreversible apoptogens for cancer epithelial cells from human prostate in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Intraperitoneal treatment with dimethylthioampal (DIMATE) combined with surgical debulking is effective for experimental peritoneal carcinomatosis in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Reactive oxygen species in melanoma and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Possible mutagens derived from lipids and lipid precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Beyond reactive oxygen species: aldehydes as arbitrators of alarm and adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Update on the aldehyde dehydrogenase gene (ALDH) superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Cellular Mechanisms of Oxidative Stress and Action in Melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Aldehyde dehydrogenase 1A1 in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Selection of tumorigenic melanoma cells using ALDH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Quiescent, Slow-Cycling Stem Cell Populations in Cancer: A Review of the Evidence and Discussion of Significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Slow-cycling therapy-resistant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Efficient tumour formation by single human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Induction of differentiation in human HL-60 cells by 4-hydroxynonenal, a product of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Treatment of the budding yeast Saccharomyces cerevisiae with the lipid peroxidation product 4-HNE provokes a temporary cell cycle arrest in G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Relationship between the mechanisms of the esterase and dehydrogenase activities of the cytoplasmic aldehyde dehydrogenase from sheep liver. An alternative view

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Antioxidant defenses in the ocular surface.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Mechanisms involved in the protection of UV-induced protein inactivation by the corneal crystallin ALDH3A1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Cross-linking of DNA in liver and testes of rats fed 1,3-propanediol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Increased sensitivity to peroxidizing agents is correlated with an imbalance of antioxidants in normal melanocytes from melanoma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Inhibition of D1, D2, and A-cyclin expression in HL-60 cells by the lipid peroxydation product 4-hydroxynonenal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2017.160

7 January 2021

inferred from DOI database lookup

Retinal Oxidation Activity and Biological Role of Human Cytosolic Aldehyde Dehydrogenase

1 reference

12 December 2020

The carcinostatic and proapoptotic potential of 4-hydroxynonenal in HeLa cells is associated with its conjugation to cellular proteins

1 reference

12 December 2020

The dual PI3K/mTOR inhibitor PI-103 promotes immunosuppression, in vivo tumor growth and increases survival of sorafenib-treated melanoma cells.

1 reference

12 December 2020

α,β-Acetylenic amino thiolester inhibitors of aldehyde dehydrogenases 1&3: suppressors of apoptogenic aldehyde oxidation and activators of apoptosis

1 reference

12 December 2020